PSIG vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 25, 2026

PSIG

32.5
AI Score
VS
NIVF Wins

NIVF

54.6
AI Score

Investment Advisor Scores

PSIG

33score
Recommendation
SELL

NIVF

55score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PSIG NIVF Winner
Revenue 53.15M 4.73M PSIG
Net Income -15.21M 9.88M NIVF
Gross Margin 1.9% 20.2% NIVF
Net Margin -28.6% 209.0% NIVF
Operating Income -1.53M -10.73M PSIG
ROE 404.1% 37.1% PSIG
ROA -44.1% 30.2% NIVF
Total Assets 34.53M 32.72M PSIG
Cash 8.94M 758,621 PSIG
Current Ratio 0.79 3.12 NIVF
Free Cash Flow -5.55M -11.06M PSIG

Relative Price Performance (Last 90 Days)

PSIG 1M: +72.7% · 3M: -73.2% NIVF 1M: -46.4% · 3M: -28.3%

Current Technical Phase

PSIG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.3 · Price: $2.09

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.8%), weak momentum, RSI 40

RSI (14): 39.8 · Price: $0.56

Fundamentals Snapshot

Metric PSIG NIVF
Market Cap
Forward P/E 0.0 0.0
Trailing P/E 0.0
Revenue (TTM)
Revenue Growth -0.4% 0.1%
Gross Margin 0.0% 0.2%
Operating Margin 0.0% -3.5%
EPS -3.81 109.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.